Consistent with this hypothesis, adoptive transfer of RORγt+ FOXP3+ Th17 Tregs completely abrogated the development of inflammation in a mouse colitis model, and displayed increased suppressive capacity in vivo compared to conventional RORγt− FOXP3+ Tregs [25]. The gene discussed is FOXP3; the disease is colitis.